Max Estates Ltd (MAXESTATES) Q1FY27 Concall Summary - Jun-2026 Qtr
Performance Overview
- Max Estates delivered a strong Q1 FY27, highlighted by a 5x year-on-year growth in pre-sales, reaching approximately INR 1,100 crores, demonstrating robust brand strength and product positioning despite a cautious national demand environment.
- The company successfully launched and sold out Phase 1 of 'The Terraces' at Estate 361 in Gurgaon, contributing INR 500 crores to the quarterly pre-sales, with sustenance sales from the existing portfolio adding another INR 600 crores.
- The commercial portfolio continues to exhibit strength, with all three operational assets—Max Towers, Max House, and Max Square—maintaining 100% occupancy, validating the quality of the assets and strong tenant demand in their respective micro-markets.
- The company received its first-time issuer credit rating of 'A+ with a stable outlook' from ICRA, an independent validation of its financial health, backed by committed receivables of nearly INR 9,500 crores and a cash flow adequacy ratio of 1.05x.
- The company is advancing its construction pipeline for both residential and commercial segments, with a clear launch pipeline of approximately INR 16,100 crores in residential GDV and an expected annual rental income of INR 700 crores from the commercial portfolio at peak occupancy.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.